Stay updated on Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial
Sign up to get notified when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.

Latest updates to the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page
- Check2 days agoChange DetectedNew record versions 424–428 dated 2026-03-26 to 2026-04-02 have been added, including Study Status updates in the history.SummaryDifference0.2%

- Check9 days agoChange DetectedNew history entries were added for Study Status on 2026-03-25 and earlier dates (versions 422–418), updating the record's status timeline.SummaryDifference0.2%

- Check16 days agoChange DetectedAdded Study Status entries with current status updates and updated revision information (Revision: v3.5.0) on the history page. Removed Revision: v3.4.3.SummaryDifference0.2%

- Check24 days agoChange DetectedAdded the Study Status entry to the history and updated the revision to v3.4.3 (replacing v3.4.2).SummaryDifference0.2%

- Check31 days agoChange DetectedThe record history shows additions of Contacts/Locations and Study Status on 2026-03-03 (and an earlier 2026-02-11 entry) and a deletion on 2025-12-05.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded the Revision: v3.4.2 entry to the history and removed the previous operating-status notice along with Revision: v3.4.1 from the page.SummaryDifference0.1%

Stay in the know with updates to Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.